✨ Free AI Report
Abbott Laboratories: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Abbott Laboratories
Company Research

Abbott Laboratories: Business Overview, Financials & Competitive Analysis

Abbott Laboratories scores 7/10 on the AskCyborg Cyborg Score (Strong). Abbott is a defensive growth play with a fortress balance sheet, growing dividend, and exposure to secular healthcare trends through CGM, structural heart, and pending cancer diagnostics acquisition. Abbott has increased its dividend payout for 54 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index. The.

What is Abbott Laboratories's industry? Abbott Laboratories (abbott.com) operates in Diversified Healthcare (Medical Devices, Diagnostics, Pharmaceuticals, Nutrition). AskCyborg classifies Abbott Laboratories under Diversified Healthcare (Medical Devices, Diagnostics, Pharmaceuticals, Nutrition) in its company registry.

Abbott is a global healthcare leader with a portfolio of life-changing technologies spanning diagnostics, medical devices, nutritionals and branded generic medicines. The company has 115,000 colleagues serving people ...

7/ 10Strong

Cyborg Score thesis

Abbott is a defensive growth play with a fortress balance sheet, growing dividend, and exposure to secular healthcare trends...

Read the full analyst-debate transcript →
Industry Diversified Healthcare (Medical Devices, Diagnostics, Pharmaceuticals, Nutrition)
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Abbott Laboratories Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Abbott Laboratories

AskCyborg analysts argue the bull and bear cases for Abbott Laboratories across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Abbott Laboratories OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Abbott Laboratories Overview

Pro stress-test →

Abbott is a global healthcare leader with a portfolio of life-changing technologies spanning diagnostics, medical devices, nutritionals and branded generic medicines. The company has 115,000 colleagues serving people in more than 160 countries. Abbott has successfully transitioned from pandemic-era COVID-19 testing revenues to a diversified growth platform anchored in metabolic health biowearables and structural heart technologies.

Strategic Profile

Pro stress-test →

The company has shifted from COVID-19 testing toward a future anchored in metabolic health and consumer-facing biowearables, solidifying its position as a defensive growth stock. The FreeStyle Libre platform is Abbott's crown jewel—the Libre 3 is the world's most widely used Continuous Glucose Monitor, on track to reach $10 billion in annual revenue by 2028. Abbott announced an agreement to acquire Exact Sciences, positioning the company to enter and lead in the fast-growing cancer diagnostics market, with transaction expected to close in Q2 2026.

Competitive Landscape

Pro stress-test →

In nutrition, Abbott competes against Nestlé and Danone, relying on its clinical heritage to maintain doctor-recommended status. In diabetes and cardiovascular devices, Abbott faces competition from traditional medical device manufacturers, while its Lingo biowearable competes with consumer health tech companies. GLP-1 manufacturers like Novo Nordisk and Eli Lilly were initially feared as threats, but data now shows synergistic usage with Abbott's CGM platforms.

Industry Context

Abbott Laboratories operates in Diversified Healthcare (Medical Devices, Diagnostics, Pharmaceuticals, Nutrition).

Key facts

Founded: 1888 · Headquarters: Abbott Park, Illinois, United States · Employees: 115000 · Revenue: $46.5B · Market cap: $200B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Abbott Laboratories.

  • GLP-1 users are more likely to use Abbott's CGMs to manage their diets and monitor drug effects, creating a positive tailwind rather than competitive threat
  • CGM sales exceeded $7.5 billion in 2025, marking the third consecutive year of adding more than $1 billion in sales
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Abbott announced CE Mark approval for TactiFlex Duo Ablation Catheter to treat atrial fibrillation
  • December 2025FDA approval for Volt PFA System, Abbott's first pulsed field ablation offering in the United States
  • +1 moreTrack every material event for Abbott Laboratories as it happens. Explore monitoring →
Get alerted when Abbott Laboratories has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Medtronic DevicesCardiovascular and diabetes devices→Apple Watch/HealthConsumer health tracking and biowearables→Insulin & GLP-1 DrugsDiabetes and weight-loss pharmaceuticals→Nutrition ProductsClinical and consumer nutrition→

Compare Abbott Laboratories with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Abbott Laboratories operates in Diversified Healthcare (Medical Devices, Diagnostics, Pharmaceuticals, Nutrition). See how the rest of the sector scores on the Cyborg framework.

Browse Diversified Healthcare (Medical Devices, Diagnostics, Pharmaceuticals, Nutrition) research →
NEW · MCP server

Ask your AI assistant about Abbott Laboratories

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Abbott Laboratories and its top competitor on Cyborg Score”
“What did Abbott Laboratories do this quarter?”
“Is Abbott Laboratories a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Abbott Laboratories do?+
Abbott is a global healthcare leader with a portfolio of life-changing technologies spanning diagnostics, medical devices, nutritionals and branded generic medicines. The company has 115,000 colleagues serving people ...
What is Abbott Laboratories's Cyborg Score?+
Abbott Laboratories has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Abbott Laboratories's main competitors?+
Named competitors include Medtronic Devices, Apple Watch/Health, Insulin & GLP-1 Drugs, Nutrition Products. The full competitive landscape is in the AskCyborg report.
How can I get the full Abbott Laboratories research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Abbott Laboratories research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Abbott Laboratories over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Diversified Healthcare (Medical Devices research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Abbott Laboratories